Protagonist Therapeutics, Inc. (PTGX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.55B |
| Enterprise Value | 5.43B |
| P/E Ratio | 26.15 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 15.82 |
| Price/Book Ratio | 8.25 |
| Enterprise/Revenue | 14.93 |
| Enterprise/EBITDA | 23.44 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.62 |
| Operating Margin | 0.59 |
AD
Management Effectiveness
| Return On Assets | 0.3 |
| Return On Equity | 0.43 |
Income Statement
| Revenue | 46.02M |
| Revenue/Share | 8.31 |
| Gross Profit | 44.79M |
| EBITDA | -128.03M |
| Net Income | -130.15M |
| Diluted EPS | -2.05 |
Balance Sheet
| Total Cash | 800.06M |
| Total Cash/Share | 12.06 |
| Total Debt | 8.63M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 19.85 |
| Book Value Per Share | 16.35 |
Price History
| 52-Week Change | 57.62 |
| 52-Week High | 160.81 |
| 52-Week Low | 77 |
| Moving Average 50 Days | 141.12 |
| Moving Average 200 Days | 118.51 |
Statistics
| Average Volume | 662,246 |
| Shares Outstanding | 64.71M |
| % Held by Institutions | 115.84 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
